AGIO

AGIO R&D Expenses

$352.75MTTM · USD

Period ending:

AGIO FY R&D ExpensesUSD
AGIO FY R&D Expenses2011-12-31: $31.25M2012-12-31: $41.04M2013-12-31: $54.50M2014-12-31: $100.37M2015-12-31: $141.83M2016-12-31: $220.16M2017-12-31: $292.68M2018-12-31: $341.32M2019-12-31: $410.89M2020-12-31: $211.02M2021-12-31: $256.97M2022-12-31: $279.91M2023-12-31: $288.90M2024-12-31: $301.29M2025-12-31: $334.36M$410.89M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AGIO r&d expenses history

Research and development spending. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Agios Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
334,358,000
301,286,000
288,903,000
279,910,000
256,973,000
211,021,000
410,894,000
341,324,000
292,681,000
220,163,000
141,827,000
100,371,000
54,502,000
41,037,000
31,253,000

Compare r&d expenses

All AGIO financial metrics · AGIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.